About this trial
Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and widely used clinically, but whose mid- to long-term clinical results are still unknown, is superior to conventional polyethylene in vivo. The aim of this project is to conduct an international multi-center joint research study to determine whether polyethylene wear debris production can be reduced in the future, using an in vivo polyethylene wear debris analysis method that the investigators developed as a method that can provide early feedback.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing revision hip arthroplasty within the study period
Patients over 20 years old
Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
Patients who have passed 2 years or more since their first total hip arthroplasty
Disqualifiers
None
Trial population
Patients undergoing revision hip arthroplasty within the study period
Trial design
Cohort
Prospective
Treatments tested in this trial
polyethylene
DeviceNo intervention as this is an observational study
Treatment groups
Trial outcomes
Primary outcomes
Number of polyethylene wear particles
counts / g (tissue sample)
Equivalent circle diameter of polyethylene wear particles
equivalent circle diameter \[㎛\]
Aspect ratio of polyethylene wear particles
aspect ratio
Roundness of polyethylene wear particles
roundness
Secondary outcomes
Body mass index
kg/m2
Hip joint flexion angle
Degrees
Hip joint exertion angle
Degrees
Hip joint adduction angle
Degrees
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Osaka Metropolitan University
Lead sponsor
Mayo Clinic
Collaborator
Hospital for Special Surgery, New York
Collaborator
Istituto Ortopedico Rizzoli
Collaborator